Taysha Gene Therapies
TSHA
#6715
Rank
NZ$0.82 B
Marketcap
$4.03
Share price
46.63%
Change (1 day)
78.67%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2023 (TTM): -$3.75

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -$3.86. In 2022 the company made an earnings per share (EPS) of -$6.41 an increase over its 2021 EPS that were of -$7.81.

EPS history for Taysha Gene Therapies from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.75-41.55%
2022-$6.41-17.93%
2021-$7.8169.11%
2020-$4.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.68-4.80%๐Ÿ‡บ๐Ÿ‡ธ USA